Gufic Biosciences Limited
Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products.
What Gufic files
- Others58
- Investor Meet27
- Updates12
- Important11
- Board Meeting10
- PPTs3
Gufic Biosciences has received a rating reaffirmation from CRISIL Ratings for its total bank loan facilities of Rs. 516 Cr (enhanced from Rs. 425 Cr). The long-term rating stands at CRISIL A-/ Stable and the short-term rating at CRISIL A2+, both successfully reaffirmed. This reflects continued stability in the company's...
Gufic Biosciences Limited has submitted the Exchange a copy of Scrutinizers report and voting results of 42nd Annual General Meeting held on September 04, 2026
Gufic Biosciences Limited has informed the Exchange regarding Proceedings of 42nd Annual General Meeting held on September 04, 2026
Gufic Biosciences promoted Ms. Ami Shah to Head-Legal and Mr. Pinak Padhya to President – Sales & Marketing. These key leadership appointments strengthen the company’s legal and sales functions.
Gufic Biosciences delivered strong Q1 FY27 results, with revenue at INR 260.8 Cr and PAT at INR 22.46 Cr, boosting EBITDA margin to 18.09%. The Indore plant is on track, with new depot and microsphere suites nearing completion and EU certification anticipated within 1-2 months. The company is strategically expanding...